Gangloff Scott A., Chief Technology Officer at Akero Therapeutics ($AKRO), made one open market sale of AKRO shares in the last year, totaling $46,504 on June 18, 2025. This ranks 10,466th among 11,678 insiders by sales value, well below the average of $8.6 million and 6.4 transactions. No open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | D | Common Stock | 21263 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | D | Common Stock | 5088 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | D | Stock Option (Right to Buy) | 204616 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.25% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | D | Stock Option (Right to Buy) | 73700 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.09% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | D | Stock Option (Right to Buy) | 17784 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Aug. 15, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | M | Common Stock | 2600 | $19.62 | 26,351.0000 | 79,620,128 | 10.95% | 0.00% |
| Aug. 15, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | M | Stock option (Right to Buy) | 2600 | $0.00 | 17,784.0000 | 79,620,128 | 12.76% | 0.00% |
| June 30, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | A | Common Stock | 299 | $23.87 | 23,751.0000 | 79,620,128 | 1.27% | 0.00% |
| June 18, 2025 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | S | Common Stock | 848 | $54.84 | 23,452.0000 | 79,620,128 | 3.49% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | A | Stock Option (Right to Buy) | 73700 | $0.00 | 73,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | A | Common Stock | 24300 | $0.00 | 24,300.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2024 | Akero Therapeutics, Inc. | $AKRO | Gangloff Scott A. | Chief Technology Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |